Charles J. Love, Jr. v. Denis McDonough

CourtUnited States Court of Appeals for Veterans Claims
DecidedJune 23, 2022
Docket21-1323
StatusPublished

This text of Charles J. Love, Jr. v. Denis McDonough (Charles J. Love, Jr. v. Denis McDonough) is published on Counsel Stack Legal Research, covering United States Court of Appeals for Veterans Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Charles J. Love, Jr. v. Denis McDonough, (Cal. 2022).

Opinion

UNITED STATES COURT OF APPEALS FOR VETERANS CLAIMS

NO. 21-1323

CHARLES J. LOVE, JR., PETITIONER,

V.

DENIS MCDONOUGH, SECRETARY OF VETERANS AFFAIRS, RESPONDENT.

Before MEREDITH, FALVEY, and LAURER, Judges.

ORDER

On March 2, 2021, Army veteran Charles J. Love, Jr., through counsel, petitioned the Court for extraordinary relief in the nature of a writ of mandamus. Mr. Love, whose 100% rating for prostate cancer was discontinued and replaced with a new 20% rating for prostate cancer residuals, argues that the Secretary may not implement that discontinuance until all appeals have been exhausted. He asks the Court to order the Secretary "to cease unlawfully withholding disability compensation" and "to pay him all amounts due consistent with [his] pre-reduction rating evaluation until his challenge to the reduction has run its course." Petition (Pet.) at 1. Because 38 U.S.C. § 7252(a) provides our sole source of jurisdiction and the petitioner has not shown that a writ would be in aid of that jurisdiction, we will dismiss the petition for a writ of mandamus.

I. BACKGROUND

Mr. Love served on active duty from January 1968 to March 1971. Pet., Exhibit (Ex.) 1 at Appendix (App.) 2. He is service connected for prostate cancer and was rated 100% disabled. Pet., Ex. 1 at App. 4, Ex. 5 at App. 24; see 38 C.F.R. § 4.115b, Diagnostic Code (DC) 7528 (2021). In February 2019, the VA regional office (RO) proposed to "reduce" Mr. Love's evaluation for prostate cancer, status post radical prostatectomy, from 100% to 20%, and to discontinue special monthly compensation (SMC) based on the housebound criteria. 1 Pet., Ex. 1 at App. 2-5. On

1 The note accompanying DC 7528 provides that, 6 months after treatment for prostate cancer, VA must provide an examination and any change in the 100% rating must be evaluated "subject to the provisions of § 3.105(e) of this chapter." § 4.115b. Section 3.105(e) states that when "a reduction or discontinuance of compensation payments" is considered, the beneficiary will be given 60 days for the presentation of additional evidence to show that compensation payments should be continued at their present level . . . . [and,] if additional evidence is not received within that period, final rating action will be taken and the award will be reduced or discontinued effective the last day of the month in which a 60–day period from the date of notice to the beneficiary of the final rating action expires. 38 C.F.R. § 3.105(e) (2021). This Court's recent decision in Foster v. McDonough characterizes the change in ratings under DC 7528 not as a "rating reduction" but as a "discontinuance" of the 100% prostate cancer rating and a grant of a prostate cancer residual rating. 34 Vet.App. 338, 345 (2021). Even so, the relevant law here does not distinguish between a "reduction" or a "discontinuance." See, e.g., § 3.105(e) ("[A] rating proposing the reduction or February 13, 2019, VA sent a letter notifying Mr. Love of the proposed change in rating that would reduce his monthly payments from $3,530.47 to $3,165.70. Secretary's (Sec'y's) Response (Resp.), Attachment (Attach.) A at 1-3. He was informed that he had 60 days to submit additional evidence and 30 days to seek a hearing to contest the change. Id. at 2; see § 3.105(e), (i). On April 3, 2019, Mr. Love challenged the proposed change, arguing that VA had not complied with 38 C.F.R. § 3.344(a). Pet., Ex. 2 at App. 7-10.

In September 2019, the RO issued a decision that discontinued the 100% prostate cancer rating and SMC, and granted a 20% rating for prostate cancer residuals, effective December 1, 2019. Pet., Ex. 3 at App. 12-15. In October 2019, VA sent Mr. Love a letter notifying him of the RO's decision. Sec'y's Resp., Attach. B. In December 2019, Mr. Love filed a Notice of Disagreement and requested direct review. Pet., Ex. 5 at App. 22-31. In December 2020, the Board of Veterans' Appeals decided that the discontinuance of the 100% rating and SMC at the housebound rate, effective December 1, 2019, was proper. Pet., Ex. 6 at App. 37-50. Mr. Love appealed to this Court in February 2021, and his appeal is pending as Love v. McDonough, U.S. Vet. App. No. 21-1265 (Notice of Appeal filed Feb. 26, 2021).

On March 2, 2021, Mr. Love petitioned for extraordinary relief, arguing that VA may not decrease his payments until his appeals are exhausted and that thus the Secretary is unlawfully withholding payment in the pre-discontinuance amount. Pet. at 1-2. On October 22, 2021, the Court heard oral arguments, and the parties later submitted supplemental briefing.

II. ARGUMENTS

In his petition for a writ of mandamus, Mr. Love asks this Court to find that the Secretary's reduction in benefits was unlawfully premature and order the Secretary to resume payment in the pre-discontinuance amount until his appeals are exhausted. Pet. at 2. He advances three grounds for this Court to exercise its authority to grant extraordinary relief. First, he argues that the Secretary's action (refusing to continue payment in the pre-discontinuance amount) has precluded a future appeal of any potential overpayment dispute, thereby thwarting this Court's prospective jurisdiction under 38 U.S.C. § 7252(a) and warranting a writ in aid of our jurisdiction under the All Writs Act (AWA). Pet. at 11, 14; see 28 U.S.C. § 1651(a). Second, he argues that, having "opened the jurisdictional door" with the AWA, 38 U.S.C. § 7261(a)(2) authorizes this Court to "compel action of the Secretary unlawfully withheld." Pet. at 12 & n.1; Petitioner's (Pet'r's) Supplemental (Suppl.) Resp. at 8. Third, he argues that this Court has jurisdiction and may issue a writ "in aid of Federal Circuit jurisdiction" based on section 7252(c). Pet. at 3-11; Pet'r's Reply at 2-7.

The Secretary responds that Mr. Love is not entitled to a writ of mandamus because the ordinary appeals process provides him with adequate alternative means to obtain his requested relief. Sec'y's Resp. at 11-17. He argues that the Secretary's action to implement a discontinuance is either a ministerial act that flows from that discontinuance decision, and thus not a separate decision under 38 U.S.C. § 511, Sec'y's Suppl. Resp. at 2-3, or a separate question that falls under

discontinuance will be prepared.") (emphasis added). Although the parties refer to "reduction" and "discontinuance" interchangeably, we will use "discontinuance" to describe the VA action.

2 a law that affects the provision of benefits such that Mr. Love would be entitled to a decision on the matter if he had appealed the effective date of the discontinuance, id. at 3-5. In either case, the Secretary maintains that issuance of a writ is unwarranted because Mr. Love has launched no action before the Agency to challenge the implementation date nor has he requested an appealable decision. Id. at 5-7.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sheldon v. Sill
49 U.S. 441 (Supreme Court, 1850)
McNutt v. General Motors Acceptance Corp.
298 U.S. 178 (Supreme Court, 1936)
Roche v. Evaporated Milk Assn.
319 U.S. 21 (Supreme Court, 1943)
Griffin v. Oceanic Contractors, Inc.
458 U.S. 564 (Supreme Court, 1982)
Block v. Community Nutrition Institute
467 U.S. 340 (Supreme Court, 1984)
Garcia v. United States
469 U.S. 70 (Supreme Court, 1985)
Christianson v. Colt Industries Operating Corp.
486 U.S. 800 (Supreme Court, 1988)
Davis v. Michigan Department of the Treasury
489 U.S. 803 (Supreme Court, 1989)
King v. St. Vincent's Hospital
502 U.S. 215 (Supreme Court, 1991)
Brown v. Gardner
513 U.S. 115 (Supreme Court, 1994)
In re: Tennant, Jame
359 F.3d 523 (D.C. Circuit, 2004)
Sharp v. United States
580 F.3d 1234 (Federal Circuit, 2009)
McGee v. Peake
511 F.3d 1352 (Federal Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Charles J. Love, Jr. v. Denis McDonough, Counsel Stack Legal Research, https://law.counselstack.com/opinion/charles-j-love-jr-v-denis-mcdonough-cavc-2022.